Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22115582
Abstract: Tolvaptan is a recently available diuretic that blocks arginine vasopressin receptor 2 in the renal collecting duct. Its diuretic mechanism involves selective water reabsorption by affecting the water reabsorption receptor aquaporin 2. Given that liver… read more here.
Keywords: cirrhotic ascites; management; management cirrhotic; ascites add ... See more keywords